Skip to content

Milk Types and Fish Oil in 9- to 12-Month-Old Infants

The Importance of Complementary Feeding on Growth, Nutritional Status and Markers for Disease. An Intervention Study With Milk Types and LC-PUFA Supplements in 9- to 12-Month-Old Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00379171
Enrollment
100
Registered
2006-09-21
Start date
2003-05-31
Completion date
2004-03-31
Last updated
2008-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Cardiovascular Disease, Growth, Metabolic Syndrome, Obesity

Keywords

Children, Complementary feeding, Breast feeding, Cow's milk, Formula, Protein, LCPUFA, Fish oil, Lipid profile, Intestinal inflammation, Intestinal microbiota

Brief summary

The objective of this intervention study is to examine the effect of whole cow's milk versus infant formula as primary milk sources with or without supplements of n-3 LCPUFA for growth, nutritional status, development, risk factors for later diseases and the impact on the intestinal microbiota and inflammation in 9 - 12 months old infants.

Interventions

BEHAVIORALCow's milk with fish oil
BEHAVIORALCow's milk without fish oil
BEHAVIORALFormula with fish oil
BEHAVIORALFormula without fish oil

Sponsors

Anjo A/S
CollaboratorUNKNOWN
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
8 Months to 12 Months
Healthy volunteers
Yes

Inclusion criteria

* Singleton infants * Born \>= 37 wk of gestation * Birth weight \> 2500g * \>= 5th percentile for gestational age * A 5-min Apgar score \>= 7 * Daily consumption of cow's milk or formula

Exclusion criteria

* No major complications at birth or in fetal life * No chronic diseases

Design outcomes

Primary

MeasureTime frame
Growth
Body composition (weight, length, knee-heel-length, waist, head, and arm circumference, skin fold measurements).
IGF-I
IGFBP-3
Insulin - glucose metabolism (HOMA index).
Urea Nitrogen
Albumin
C-peptide
Amino Acids
Erythrocyte fatty acid composition
Blood pressure
Lipid Profile
Heart Rate Variability (HRV)
In vitro cytokine production from stimulated full blood (IL-10, IFN-gamma, TNF-alpha)
Plasma IgE, IL-2R, and CRP

Secondary

MeasureTime frame
Plasma concentrations of cholesterol and triglycerides
Allergy status
Cognitive test (The infant means-end problem solving test)
Iron status (hemoglobin, ferritin and transferrin receptors)
Feces samples: Calprotectin, IgA and composition of the intestinal microbiota

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026